Cargando…
Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient
BACKGROUND: The factors determining differential HIV disease outcome among individuals expressing protective HLA alleles such as HLA-B*27:05 and HLA-B*57:01 remain unknown. We here analyse two HIV-infected subjects expressing both HLA-B*27:05 and HLA-B*57:01. One subject maintained low-to-undetectab...
Autores principales: | Brener, Jacqui, Gall, Astrid, Hurst, Jacob, Batorsky, Rebecca, Lavandier, Nora, Chen, Fabian, Edwards, Anne, Bolton, Chrissy, Dsouza, Reena, Allen, Todd, Pybus, Oliver G., Kellam, Paul, Matthews, Philippa C., Goulder, Philip J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771019/ https://www.ncbi.nlm.nih.gov/pubmed/29338738 http://dx.doi.org/10.1186/s12977-018-0390-9 |
Ejemplares similares
-
Disease progression despite protective HLA expression in an HIV-infected transmission pair
por: Brener, Jacqui, et al.
Publicado: (2015) -
Subdominant Gag-specific anti-HIV efficacy in an HLA-B(∗)57-positive elite controller
por: Leitman, Ellen M., et al.
Publicado: (2016) -
Unravelling the Proteomics of HLA-B*57:01(+) Antigen Presenting Cells during Abacavir Medication
por: Haukamp, Funmilola Josephine, et al.
Publicado: (2022) -
IVA: accurate de novo assembly of RNA virus genomes
por: Hunt, Martin, et al.
Publicado: (2015) -
Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts
por: Brown, Robin, et al.
Publicado: (2022)